Sri Lanka Drug Registration 2026: Complete NMRA Pharmaceutical, OTC & Medicine Approval Guide (MOH, GMP, Dossier & Regulatory Process)

Sri Lanka’s pharmaceutical regulatory framework is governed by the Ministry of Health (MOH) and the National Medicines Regulatory Authority (NMRA). These authorities ensure that all medicines, including prescription drugs, OTC products, and generics, meet stringent standards for quality, safety, and efficacy before entering the market.

With increasing focus on drug quality surveillance, GMP enforcement, and regulatory harmonization, Sri Lanka continues to strengthen its pharmaceutical regulatory ecosystem in 2026.

This comprehensive guide by Maven Regulatory Solutions provides a detailed overview of drug registration in Sri Lanka, including regulatory authorities, legal framework, dossier requirements, GMP compliance, and approval pathways.

Sri Lanka Pharmaceutical Regulatory Overview

Regulatory Authorities & Legal Framework

1. Ministry of Health (MOH)

The Ministry of Health oversees national healthcare policies and regulatory governance. It ensures that pharmaceutical regulations align with public health objectives and global standards.

Official Website: https://www.health.gov.lk/

2. National Medicines Regulatory Authority (NMRA)

The National Medicines Regulatory Authority is the primary authority responsible for:

• Evaluation and approval of pharmaceutical products 
• Licensing of manufacturers and importers 
• Post-market surveillance and pharmacovigilance 
• Enforcement of regulatory compliance 

Regulatory Website: https://www.nmra.gov.lk/

Legal Framework: CDD Act

Drug regulation in Sri Lanka is based on the Cosmetics, Devices, and Drugs Act No. 27 of 1980, amended by subsequent acts.

Key Legal Highlights:

• Governs manufacture, import, distribution, and sale of drugs 
• Defines registration requirements and quality standards 
• Enables regulatory enforcement actions 

Gazette Notification

Regulations were initially published under Gazette Extraordinary No. 378/3 (1985) and are periodically updated to reflect evolving regulatory needs.

Role of CDDA (Historical Context & Regulatory Evolution)

The Cosmetics, Devices and Drugs Authority (CDDA) historically functioned as the regulatory body responsible for drug approvals.

Expanded Role:

• Drug registration and evaluation 
• GMP compliance verification 
• Regulatory recommendations 

Today, NMRA has assumed broader responsibilities, modernized the regulatory framework and aligned with international best practices and WHO guidelines.

Local Authorized Representative (LAR) Requirement

Mandatory Requirement: YES

Foreign manufacturers must appoint a local authorized agent in Sri Lanka.

Responsibilities of Local Agent:

• Submit registration applications to NMRA 
• Act as liaison with regulatory authorities 
• Handle post-approval compliance and renewals 
• Manage import licenses and distribution 

Key Insight:

A reliable LAR ensures smooth communication, faster approvals, and regulatory compliance continuity.

Sri Lanka Drug Registration Process (Step-by-Step)

1. GMP Compliance Assessment

The first and most critical step is verifying Good Manufacturing Practice (GMP) compliance.

GMP Evaluation Process

Key Requirements:

• Valid GMP certificate 
• Site Master File 
• Quality system documentation 

2. Dossier Submission & Documentation

Applications must be submitted through the local agent along with product samples.

Core Dossier Components:

• Administrative documents 
• Product formulation details 
• Manufacturing process 
• Stability data 
• Clinical/BE data (if applicable) 
• Labeling and packaging 

3. Submission to MT&S Division

The dossier and samples are submitted to the Medical Technology & Supplies (MT&S) division under the Ministry of Health.

Role of MT&S:

• Initial application screening 
• Coordination with evaluation committees 
• Sample testing coordination 

4. Technical Evaluation (DESC Committee)

The Drug Evaluation Sub-Committee (DESC) evaluates the application.

Evaluation Focus:

• Quality of the product 
• Safety profile 
• Therapeutic efficacy 

Expert Insight:

DESC includes experts from medical, pharmaceutical, and scientific domains, ensuring a multi-disciplinary evaluation process.

5. Laboratory Testing (NDQAL)

The National Drug Quality Assurance Laboratory (NDQAL) conducts:

• Product testing 
• Quality verification 
• Batch consistency analysis 

6. Approval & Registration

Once all requirements are satisfied:

• NMRA grants marketing authorization 
• Product is registered for sale in Sri Lanka 

Drug Registration Workflow Summary

Renewal of Drug Registration

Renewal Timeline

• Must be submitted 6 months before expiry 

Key Conditions:

• Continued compliance with registration requirements 
• Updated safety and quality data 
• No regulatory violations 

Grace Period:

• Allowed until renewal decision is finalized 

Important Note:

Failure to meet conditions may result in:

• Application rejection 
• Suspension of product registration 

Key Compliance Requirements for 2026

• GMP compliance aligned with WHO/PIC/S standards 
• Updated pharmacovigilance systems 
• Stability data for tropical climates 
• Accurate labeling and serialization 
• Strong documentation and traceability 

Future Regulatory Developments in Sri Lanka

• Establishment of Pharmaceutical Standards Regulatory Authority 
• Stronger enforcement against substandard drugs 
• Increased regulatory inspections 
• Digitalization of submission processes 
• Alignment with global regulatory harmonization initiatives

Conclusion

Sri Lanka’s pharmaceutical registration process is robust, structured, and evolving toward global harmonization. From GMP compliance to dossier submission and regulatory evaluation, each step ensures that only safe, effective, and high-quality medicines reach the market.

Maven Regulatory Solutions supports pharmaceutical companies with:

• End-to-end NMRA registration strategy 
• Dossier preparation and compliance 
• GMP consulting 
• Lifecycle management and renewals 

FAQs – Sri Lanka Drug Registration

1. Is a local agent mandatory in Sri Lanka?

Yes, foreign manufacturers must appoint a local authorized representative.

2. What is the main regulatory authority?

NMRA is the primary regulatory authority under the Ministry of Health.

3. What are the key approval criteria?

Quality, safety, and efficacy.

4. How long does registration take?

Typically, 6–12 months, depending on dossier completeness.

5. When should renewal be applied?

At least 6 months before expiry.